Elimination of HSV-2 infected cells is mediated predominantly by paracrine effects of tissue-resident T cell derived cytokines
P. Roychoudhury, D. A. Swan, E. Duke, L. Corey, J. Zhu, V. Dave, L. Richert Spuhler, J. M. Lund, M. Prlic, J. Schiffer
Abstract
The mechanisms underlying rapid elimination of herpes simplex virus-2 (HSV-2) in the human genital tract despite low tissue-resident CD8+ T-cell density (TRM) are unknown. We analyzed shedding episodes during chronic HSV-2 infection: viral clearance always occurred within 24 hours of detection even if viral load exceeded 107 HSV DNA copies; surges in granzyme B and interferon-{gamma} occurred within the early hours after reactivation. We next developed a mathematical model of an HSV-2 genital ulcer to integrate mechanistic observations of TRM in situ proliferation, trafficking, cytolytic effects and cytokine alarm signaling from murine studies with viral kinetics, histopathology and lesion size data from humans. A sufficiently high density of HSV-2 specific TRM predicted rapid contact-mediated elimination of infected cells. At lower TRM densities, TRM must initiate a rapidly diffusing, polyfunctional cytokine response in order to eliminate of a majority of infected cells and eradicate briskly spreading HSV-2 infection.\n\nOne Sentence SummaryControl of herpes simplex virus-2 is primarily mediated by rapidly diffusing cytokines secreted by tissue-resident T cells.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- B cells and HSV-specific antibodies respond to HSV-2 reactivation in skin
Emily S. Ford, Anton M. Sholukh, … Lawrence Corey·bioRxiv·Jul 8, 2020
- Therapeutic Prime/Pull Vaccination of HSV-2 Infected Guinea Pigs with the Ribonucleotide Reductase 2 (RR2) Protein and CXCL11 Chemokine Boosts Antiviral Local Tissue-Resident and Effector Memory CD4+ and CD8+ T Cells and Protects Against Recurrent Genital Herpes
L. BenMohamed, A. Quadiri, … H. Schaefer·bioRxiv·Aug 8, 2023
- High Frequencies of Antiviral Effector Memory TEM Cells and Memory B Cells Mobilized into Herpes Infected Vaginal Mucosa Associated With Protection Against Genital Herpes
N. R. Dhanushkodi, S. Prakash, … L. BENMOHAMED·bioRxiv·May 23, 2023
- Genital herpes shedding episodes associate with alterations in the spatial organization and activation of mucosal immune cells
Finn MacLean, Rachael M. Zemek, … the Kinga Study Team·bioRxiv·Jun 24, 2025
- A Prime/Pull RR2/CXCL11 Therapeutic Vaccine that Bolsters the Number and Function of Dorsal Root Ganglia Tissue-Resident HSV-Specific CD8+ TRM Cells Protects Latently Infected Guinea Pigs from Recurrent Genital Herpes
N. Dhanushkodi, S. Prakash, … L. BenMohamed·bioRxiv·Jul 22, 2022
- Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus-2 Release from Cells
J. Hopkins, T. Yadavalli, … D. Shukla·bioRxiv·Jul 8, 2018